Cargando…

Prolonged dual antiplatelet therapy in patients with non‐ST‐segment elevation myocardial infarction: 2‐year findings from EPICOR Asia

BACKGROUND: Patients with non‐ST‐segment elevation myocardial infarction (NSTEMI) have a generally poor prognosis and antithrombotic management patterns (AMPs) used post‐acute coronary syndrome (ACS) remain unclear. Duration of dual antiplatelet therapy (DAPT) and patient characteristics was evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Yanan, Yang, Shuang, Wang, Shipeng, Lv, Bo, Xiu, Lili, Li, Lulu, Lee, Stephen W.‐L., Chin, Chee Tang, Pocock, Stuart J., Huo, Yong, Yu, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2020
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144485/ https://www.ncbi.nlm.nih.gov/pubmed/31967663 http://dx.doi.org/10.1002/clc.23322

Ejemplares similares

Long-Term Antithrombotic Therapy and Clinical Outcomes in Patients with Acute Coronary Syndrome and Renal Impairment: Insights from EPICOR and EPICOR Asia
por: Huo, Yong, et al.
Publicado: (2021)

Predictors of high-cost hospitalization in the treatment of acute coronary syndrome in Asia: findings from EPICOR Asia
por: Jan, Stephen, et al.
Publicado: (2018)

Long‐term antithrombotic management patterns in Asian patients with acute coronary syndrome: 2‐year observations from the EPICOR Asia study
por: Zheng, Bo, et al.
Publicado: (2020)

Evaluation of the EpiCore outbreak verification system
por: Lorthe, Taryn Silver, et al.
Publicado: (2018)

Safety of Antiplatelet Pretreatment in Non-ST-segment Elevation Acute Coronary Syndrome
por: Torres-Ruiz, G, et al.
Publicado: (2023)

Prehospital and in-hospital use of healthcare resources in patients surviving acute coronary syndromes: an analysis of the EPICOR registry
por: Annemans, Lieven, et al.
Publicado: (2016)

Impact of Diabetes Mellitus on Antithrombotic Management Patterns and Long‐Term Clinical Outcomes in Patients With Acute Coronary Syndrome: Insights From the EPICOR Asia Study
por: Guan, Shaoyi, et al.
Publicado: (2020)

Characteristics and mechanism of reciprocal ST-segment depression in acute ST segment elevation myocardial infarction: Reciprocal ST-segment depression and ST segment elevation myocardial infarction
por: Gao, Qijun, et al.
Publicado: (2022)

EpiCore: Crowdsourcing Health Professionals to Verify Disease Outbreaks
por: Olsen, Jennifer M.
Publicado: (2017)

Risks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic Review
por: Nascimento, Bruno Ramos, et al.
Publicado: (2014)

Short- and long-term follow-up of antithrombotic management patterns in patients hospitalized with acute coronary syndrome: Indian subgroup of EPICOR Asia study
por: Sawhney, J.P.S., et al.
Publicado: (2019)

Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST‐segment elevation myocardial infarction
por: Welsh, Robert C., et al.
Publicado: (2021)

Dietary Glycemic Load and Glycemic Index and Risk of Cerebrovascular Disease in the EPICOR Cohort
por: Sieri, Sabina, et al.
Publicado: (2013)

A potential diagnostic pitfall in ST elevation: Acute pulmonary embolism or ST‐segment elevation myocardial infarction
por: Zheng, Bo, et al.
Publicado: (2021)

Acute ST-elevation Myocardial Infarction after Upper Gastrointestinal Bleeding: A Clinical Dilemma of Antiplatelet Therapy
por: Xue, Wen-Qiang, et al.
Publicado: (2018)

Prolonged Fever After ST‐Segment Elevation Myocardial Infarction and Long‐Term Cardiac Outcomes
por: Kawashima, Chika, et al.
Publicado: (2017)

Secondary rotational atherectomy is associated with reduced occurrence of prolonged ST-segment elevation following ablation
por: Kanda, Daisuke, et al.
Publicado: (2023)

Invasive and antiplatelet treatment of patients with non‐ST‐segment elevation myocardial infarction: Understanding and addressing the global risk‐treatment paradox
por: Ahrens, Ingo, et al.
Publicado: (2019)

Impact of ST-segment elevation on the outcome of Takotsubo syndrome
por: Gietzen, Thorsten, et al.
Publicado: (2019)

Effectiveness of dual antiplatelet de-escalation therapy on the prognosis of patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention
por: Zhao, Zhigang, et al.
Publicado: (2023)

Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study
por: Pocock, Stuart, et al.
Publicado: (2015)

ST Segment Elevation with Normal Coronaries
por: Sethi, Pooja, et al.
Publicado: (2016)

False-positive ST-segment elevation
por: Tanabe, Junya, et al.
Publicado: (2020)

Cause of ST-segment elevation on electrocardiogram
por: Soh, Rodney Yu-Hang, et al.
Publicado: (2022)

ST-Segment Elevation: An Unexpected Culprit
por: Sá Couto, David, et al.
Publicado: (2023)

Prolonged cardiac arrest complicating a massive ST-segment elevation myocardial infarction associated with marijuana consumption
por: Orsini, Jose, et al.
Publicado: (2016)

aVR ST‐segment changes and prognosis of ST‐segment elevation myocardial infarction
por: Sedighi, Sogol, et al.
Publicado: (2021)

Ablation of atrial fibrillation with the Epicor system: a prospective observational trial to evaluate safety and efficacy and predictors of success
por: Schopka, Simon, et al.
Publicado: (2010)

When is the Best Time for the Second Antiplatelet Agent in Non-St Elevation Acute Coronary Syndrome?
por: Silva, Pedro Gabriel Melo de Barros e, et al.
Publicado: (2016)

Management of ST-elevation myocardial infarction in the setting of anterior epistaxis: focused on antiplatelet and antithrombotic therapies
por: Handoyo, Victoria, et al.
Publicado: (2019)

Not Every ST-Segment Elevation Is a STEMI
por: Merlo, Andrea C., et al.
Publicado: (2021)

An embolic ST-segment elevation myocardial infarction
por: Feng, Lv, et al.
Publicado: (2021)

Acute ST-segment elevation myocardial infarction: to be or not to be?
por: Barbur, Maria Carolina Manzur, et al.
Publicado: (2022)

An uncommon cause of anterior ST-segment elevation
por: Ballesteros, Ravi Vazirani, et al.
Publicado: (2023)

Left ventricular function, strain, and infarct characteristics in patients with transient ST-segment elevation myocardial infarction compared to ST-segment and non-ST-segment elevation myocardial infarctions
por: Demirkiran, Ahmet, et al.
Publicado: (2021)

Assessment of serum phenylalanine and tyrosine isomers in patients with ST‐segment elevation vs non‐ST‐segment elevation myocardial infarction
por: Al‐Sadoon, Ied, et al.
Publicado: (2020)

ST-segment elevation predicts the occurrence of malignant ventricular arrhythmia events in patients with acute ST-segment elevation myocardial infarction
por: Wang, Xianpei, et al.
Publicado: (2023)

Circulating Sulfatide, A Novel Biomarker for ST-Segment Elevation Myocardial Infarction
por: Li, Gang, et al.
Publicado: (2019)

Type 1 plasminogen activator inhibitor as a common risk factor for cancer and ischaemic vascular disease: the EPICOR study
por: Iacoviello, Licia, et al.
Publicado: (2013)

The Association between Educational Level and Cardiovascular and Cerebrovascular Diseases within the EPICOR Study: New Evidence for an Old Inequality Problem
por: Ricceri, Fulvio, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u09082ejbt9ej1i6897dl9befk